COVID-19 Treatment Study for SARS-Cov-2

COVID-19 Treatment Study for SARS-Cov-2

Tested positive for Covid -19? Join our study to participate in clinical studies for Treatments for respiratory syncytial virus (RSV) and SARS-CoV-2 (COVID-19) in your area. All study-related exams, labs, and investigational migraine medications may be provided at no cost to you.

 

Who Can Participate
Male / Female
Age 18 years and above
Tested positive for SARS-CoV-2 Had symptoms for five days or less and have not received a SARS-CoV-2 vaccine dose less than 90 days before enrollment and/or been infected with SARS-CoV-2 less than90 days of enrollment.

 

Participants May Receive:
Study related exam
Study related materials
Compensation up to $1275

We have helped tens of thousands of patients in similar studies.
Space in this study is limited. To be considered, please fill out the form or call 713-869-1825.
After you submit, a Trio Clinical patient recruitment specialist will contact you promptly.

Any information provided online or on the phone for the purpose of determining eligibility is considered confidential and will not be shared with other organizations or individuals.

If you are interested in one of our studies or would like to inquire about upcoming clinical trials, please call Patient Recruitment for more information between 9am – 5pm Monday – Friday.

Call 713-252-5700 now or fill in the form below and we will contact you: